NIH-funded research NIH-funded research

Investigating how specific immune cells contribute to the recurrence of gum disease

Official title: The Role of CD4+ Memory T cell Subtypes in Periodontal Disease Recurrence

Funded at State University of New York at Buffalo · NIH-11310401 · Data updated 2026-11-12

This study is looking at how certain immune cells in the body might be involved in the return of gum disease, using a special mouse model to see how these cells react to germs and affect gum health over time, which could help us find better ways to treat and prevent gum problems.

More Recurrence research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$248,999
NIH project number4R00DE032704-03
Project IDNIH-11310401 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who have experienced recurrent periodontal disease.

Less likely to help

Patients who have not been diagnosed with periodontal disease or are under 21 years old may not benefit from this research.

What this research studies

This research focuses on understanding the role of CD4+ memory T cells in the recurrence of periodontal disease, a common gum condition. By using a specialized mouse model, the researchers aim to explore how these immune cells respond to microbial antigens and their impact on gum health over time. The study will analyze how repeated episodes of periodontal disease affect the immune response and bone loss in the gums. This approach could lead to better insights into the underlying mechanisms of gum disease recurrence and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for periodontal disease, reducing its recurrence and associated complications.

How similar studies have gone: Previous research has shown that targeting immune responses can lead to significant advancements in managing chronic diseases, suggesting potential success for this approach.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Alvarez Rivas, Carla — State University of New York at Buffalo
  • Study coordinator: Alvarez Rivas, Carla

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.